Anti Nuclear Antibody Testing Market
According to Intent Market Research, the Anti-Nuclear Antibody Testing Market is expected to grow from USD 1.1 Billion in 2024-e at a CAGR of 13.0% to touch USD 2.3 Billion by 2030. The Anti-Nuclear Antibody Testing Market is dominated by key players such as Bio-Rad Laboratories, Inc., Abbott Laboratories, Trinity Biotech plc, Siemens Healthineers AG, EUROIMMUN Medizinische Labordiagnostika AG, and Inova Diagnostics, Inc.